| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 02/25/2004 | EP1390521A1 Glycopeptide antibiotics |
| 02/25/2004 | EP1390518A2 Buffer solution for electroporation and a method comprising the use of the same |
| 02/25/2004 | EP1390516A1 Novel expression vectors and uses thereof |
| 02/25/2004 | EP1390490A2 Muscle-specific expression vectors |
| 02/25/2004 | EP1390485A1 Removal of plasmin(ogen) from protein solutions |
| 02/25/2004 | EP1390475A2 Neutral progenitor cells |
| 02/25/2004 | EP1390474A1 Method for obtaining antigen-specific tr1 regulatory lymphocytes |
| 02/25/2004 | EP1390473A2 Methods and reagents for cell transplantation |
| 02/25/2004 | EP1390471A1 Method for autologous transplantation |
| 02/25/2004 | EP1390400A2 Pharmaceutical use for secreted bacterial effector proteins |
| 02/25/2004 | EP1390398A2 Adenovirus protein ix, its domains involved in capsid assembly, transcriptional activity and nuclear reorganization |
| 02/25/2004 | EP1390390A2 Human secreted proteins |
| 02/25/2004 | EP1390071A2 Symbiotic regenerative agent |
| 02/25/2004 | EP1390070A1 Use of il-18 inhibitors for treating or preventing cns injuries |
| 02/25/2004 | EP1390067A1 Compositions for use in treating ige-associated disorders |
| 02/25/2004 | EP1390064A2 Method of treating malignancies through induction of blood immune responses |
| 02/25/2004 | EP1390062A2 Modulators of elastase inhibitor secretion |
| 02/25/2004 | EP1390057A2 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and method of use |
| 02/25/2004 | EP1390054A2 Mu-conopeptides |
| 02/25/2004 | EP1390046A2 Treatment of neoplasms with viruses |
| 02/25/2004 | EP1220868B1 Extracorporeal endotoxin removal method |
| 02/25/2004 | EP0954336B1 Membrane incorporation of texaphyrins |
| 02/25/2004 | EP0929271B1 Prosthetic kidney |
| 02/25/2004 | EP0790059B1 Means for treating auto-immune diseases |
| 02/25/2004 | CN1478145A Differentiated cells suitable for human therapy |
| 02/25/2004 | CN1478143A Tumor cell internal specific proliferated virus capable of high-effectively expressing tumor angiogenesis inhibiting factor and its application |
| 02/25/2004 | CN1477979A Tissue equivalant for transplantation and process for producing the same |
| 02/25/2004 | CN1477966A Shark meat extract |
| 02/25/2004 | CN1477965A Pharmaceutical product for treatment and diagnosis of tumors and method for preparation of liqid free fraction of blood plasma |
| 02/25/2004 | CN1477964A Treatment of neoplasms with viruses |
| 02/25/2004 | CN1477954A 可消耗容器 Consumable containers |
| 02/25/2004 | CN1477190A Method and relative composition for controlling cell fusion |
| 02/25/2004 | CN1476890A Chinese medicine composition for curing child common cold fever |
| 02/25/2004 | CN1476889A Medicine for external application for curing cervical erosion |
| 02/25/2004 | CN1476866A Medicine with acupuncture and moxibustion effect and its preparation method |
| 02/25/2004 | CN1476862A Fengshitong capsule for curing rheumatalgia |
| 02/25/2004 | CN1476847A Chinese medicine oil preparation for promoting blood circulation |
| 02/25/2004 | CN1476844A Preparation method of medicine powder for curing epilepsy |
| 02/25/2004 | CN1139657C Coated microgranules for stabilizing lactic acid bacteria |
| 02/25/2004 | CN1139400C Medicine for treating arthritis and bone injury disease |
| 02/25/2004 | CN1139399C Chinese Medicine pill for treating hepatitis B and its preparing method |
| 02/25/2004 | CN1139398C Chinese medicine for treating diabetic neural lesion |
| 02/25/2004 | CN1139397C Plaster for treating hyperosteogeny and osteoarthropathy and its producing method |
| 02/25/2004 | CN1139395C Vital energy benefitting methol powder as Chinese medicine preparation for treating gastrosis |
| 02/25/2004 | CN1139394C Medicine for nourishing kidney, circulating blood, helping conception and removing spots |
| 02/25/2004 | CN1139393C Externally applied plaster and its preparing method |
| 02/25/2004 | CN1139392C Quick-acting bone-setting powder medicine |
| 02/25/2004 | CN1139390C Method for preparing health-care medicine |
| 02/25/2004 | CN1139389C Food and its making method |
| 02/25/2004 | CN1139388C Granular medicine of coral powder and its application |
| 02/24/2004 | US6696273 FEBP1 Protein: vector, host cells and method for making FEBP1 protein |
| 02/24/2004 | US6696094 Herbal pharmaceutical composition for treatment of HIV/AIDS patients |
| 02/24/2004 | US6696092 Concurrent heating, radiation, oxidation of blood; separation of leukocytes; administering |
| 02/24/2004 | US6696089 Nanogel networks including polyion polymer fragments and biological agent compositions thereof |
| 02/24/2004 | US6696074 Harvesting animal tissue from an animal source; extracting growth and differentiation factors; inactivating infective agents of tissue; mechanically expressing undesirable components from tissue; washing tissue; drying, crosslinking |
| 02/24/2004 | US6696064 Methods of protecting vasculature from damage by diphtheria toxin-and pseudomonas toxin-based immunotoxins during therapy |
| 02/24/2004 | US6696057 Composition and method for treatment of gastrointestinal disorders and hyperlipidemia |
| 02/24/2004 | US6695879 Cardiovascular components for transplantation and methods of making thereof |
| 02/24/2004 | US6695805 Systems and methods for removing free and entrained contaminants in plasma |
| 02/24/2004 | CA2219081C Angiostatin fragments and aggregate angiostatin and methods of use |
| 02/19/2004 | WO2004016297A1 Composition for filling bone defects |
| 02/19/2004 | WO2004015125A1 Process for preparing peptides with anti-hypertensive properties |
| 02/19/2004 | WO2004015118A1 Vaccinia virus host range genes to increase the titer of avipoxviruses |
| 02/19/2004 | WO2004015113A2 Albumin-fused ciliary neurotrophic factor |
| 02/19/2004 | WO2004015102A1 Olfactory ensheathing cells (oecs) in an extracellular matrix for use in axon regeneration |
| 02/19/2004 | WO2004015077A2 Compositions and methods for neural differentiation of embryonic stem cells |
| 02/19/2004 | WO2004015070A2 Isolation and identification of t cells |
| 02/19/2004 | WO2004015062A2 Methods and compositions relating to gene silencing |
| 02/19/2004 | WO2004015056A2 Immunomodulating compositions, processes for their production and uses therefor |
| 02/19/2004 | WO2004014433A1 Inhibition of proliferation and infiltration of brain tumor cells caused by expression of ampa-type glutamate receptor subunit |
| 02/19/2004 | WO2004014408A1 Intravaginal washing agent |
| 02/19/2004 | WO2004014403A1 Microorganisms for inhibiting obesity and diabetes mellitus |
| 02/19/2004 | WO2004014314A2 Methods and compositions concerning poxviruses and cancer |
| 02/19/2004 | WO2004014302A2 Mechanisms of myoblast transfer in treating heart failure |
| 02/19/2004 | WO2003100060A3 Muc-1 antigen with reduced number of vntr repeat units |
| 02/19/2004 | WO2003085092B1 Cellular transplantation for heart regeneration |
| 02/19/2004 | WO2003080640B1 Lymphatic and blood endothelial cell genes |
| 02/19/2004 | WO2003053474A3 Use of micro-organisms for a directed delivery of substances to specific parts of the gut |
| 02/19/2004 | WO2003052051A3 Adeno-associated virus (aav) serotype 8 sequences |
| 02/19/2004 | WO2003048780A3 Uses of aldose-1-epimerase (mutarotase) for diagnosis and therapy of inflammatory diseases and sepsis |
| 02/19/2004 | WO2003043576A3 Flowable osteogenic and chondrogenic compositions |
| 02/19/2004 | WO2003008537A9 Epitope sequences |
| 02/19/2004 | WO2003004622A3 Human secreted proteins |
| 02/19/2004 | WO2002076380A3 Cytotoxic factors for modulating cell death |
| 02/19/2004 | WO2002070023A3 Compositions comprising bone marrow cells together with demineralized and/or mineralized bone matrix and uses thereof in the induction of bone and cartilage formation |
| 02/19/2004 | WO2002042328A3 Method for studying the effects of commensal microflora on mammalian intestine and treatments of gastrointestinal-associated disease based thereon |
| 02/19/2004 | WO2002024214A3 Use of glp -2 in combination with another therapeutic agent in bone-related and nutrition-related disorders |
| 02/19/2004 | WO2002015887A8 Consumable container |
| 02/19/2004 | US20040034006 Combining blood product with (a porphyrin compound) a photosensitiser, and activating the photosensitiser |
| 02/19/2004 | US20040033598 Compositions and methods for generating skin |
| 02/19/2004 | US20040033597 Multipotent neural stemcells from peripheral tissues and uses thereof |
| 02/19/2004 | US20040033595 Conditionally replicating vectors for inhibiting viral infections |
| 02/19/2004 | US20040033593 Bioartificial device for the storage, cultivation and/or multiplication of cells |
| 02/19/2004 | US20040033550 Method of isolating biologically active fraction containing clinically acceptable native S-lipopolysaccharides obtained from bacteria producing endotoxic lipopolysaccharides |
| 02/19/2004 | US20040033511 Site-specific antibody-mediated activation of proapoptotic cytokines: AMAIZEe (antibody-mediated apoptosis inducing cytokines) |
| 02/19/2004 | US20040033282 Kefir extract as anti-cancer agent |
| 02/19/2004 | US20040033232 Methods and compositions for in vivo clearance of pathogens |
| 02/19/2004 | US20040033230 Breast tumor polypeptides, polynucleotides that encode them, antigen presenting cells that express them, and T cells that are specific for cells that express them. |
| 02/19/2004 | US20040033220 Use of enzymes obtained from ciliates as medicaments for promoting digestion |
| 02/19/2004 | US20040033218 Extracellular matrix (ecm); cell and genetic therapy |